Building Commercial Readiness in Advanced Therapies
August 10, 2026
Why early process development, analytical planning, and tech transfer can shape the future of cell and gene therapy manufacturing
5 min read
False
Advertisement
Latest
This Week’s CGT News: In Vivo CAR T Draws Major Investment
August 10, 2026
Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes
3 min read
Musings from The Power List: Ali Pashazadeh
By Ali Pashazadeh
August 7, 2026
Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier
7 min read
Moving Glycosylation Control Upstream
August 6, 2026
Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.
7 min read
What Did ASCO 2026 Reveal About the Future of Oncology?
By James Strachan
August 6, 2026
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades
8 min read
How China Is Rewriting the Rules Global Drug Development
By James Strachan
August 5, 2026
In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development
14 min read
Do Pharma Supply Chains Have a Visibility Problem?
By Adriana Stalteri
August 4, 2026
A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain
4 min read
The 10 Biggest Bottlenecks Slowing Drug Development
August 4, 2026
Ten industry leaders from the 2026 Power List identify the scientific, clinical, regulatory, and financial barriers holding drug development back
6 min read
This Week’s CGT News: Gene-Editing Trial Death Raises Concerns
August 3, 2026
A previously undisclosed death in China raises questions about gene-editing oversight, deramiocel meets its Phase 3 Duchenne endpoint, and researchers identify a source of CAR NK dysfunction
4 min read
2026 Innovation Awards: Nominate Now
July 31, 2026
Nominations are now open for The Medicine Maker 2026 Innovation Awards, celebrating the latest technologies for drug development and manufacturing
1 min read
